Secure your place at our upcoming conference and benefit from our Early Bird rates, which are available until 2 September 2026. Book early to save and join colleagues from across the sector for an engaging and inspiring event.
We invite patients, carers and ILD interdisciplinary team members to nominate healthcare professional(s), colleague(s) and/or team member(s) for recognition of their contribution to ILD and for going above and beyond to make a difference. Nomination deadline is 18th September 2026
There are 3 award categories this year which are all generously sponsored by Pulmonary Fibrosis Trust:

Applications for conference bursaries are now live. If you would like to apply for financial support to attend the conference, please review the guidance and complete the application form using the button below.
The deadline for applications is 17 July 2026 11:59pm
We invite submission of abstracts for presentation at the ILD-IN Annual Conference 2026. Please review abstract guidance and submit your abstract using the form below by 31st July 2026 at 11:59pm.
The Full Conference registration will include one night’s accommodation.
4th-5th October 2026
Edgbaston Park Hotel,
53 Edgbaston Park Road, Birmingham, B15 2RS
Click on each speaker to read their biographies.

Leanne is a Respiratory Nurse Specialist Lead at Asthma + Lung UK, with over 20 years’ experience in respiratory nursing across both primary and secondary care. She is an experienced respiratory nurse and independent prescriber, with a particular interest in supporting people living with complex and long-term lung conditions.In her current role, Leanne leads the clinical team supporting Asthma + Lung UK’s Helpline, providing advice and support to people living with a wide range of respiratory conditions, including interstitial lung disease. Her experience across different healthcare settings, alongside her current work with people living with lung conditions, gives her insight into the challenges of navigating care between primary, secondary and specialist services and the important role primary care plays in supporting people living with ILD.

Liz is a Consultant Radiologist at The Royal Devon University Hospital Trust in Exeter. Her radiological practice covers many areas of radiology, both acute and non-acute. She has a specialist interest in imaging of the chest, in particular interstitial lung disease, and chest oncology. Liz trained at St Mary’s hospital medical school at Imperial college, graduating in 2002. After completing basic surgical training on the Northwest London rotation, she commenced her radiological career in 2006. Liz trained on the Chelsea and Westminster Radiology scheme. During this time she spent several months at the Royal Brompton hospital which helped spark her interest in chest imaging. Liz completed her radiology training with a fellowship in cross sectional oncological imaging at the Royal Marsden Hospital, London. The family relocated to Devon in 2014 and shortly after this she joined the ILD team at Exeter. She regularly participates in the regional ILD MDT, reporting and reviewing ILD imaging.

Naomi brings over 14 years of specialist experience in Interstitial Lung Disease (ILD), having begun her career as an ILD Research Nurse. During this time, she was privileged to contribute to some of the original clinical research programmes investigating nintedanib, an experience that helped shape her passion for advancing ILD care and improving outcomes for patients. For the past several years, Naomi has worked as an ILD Specialist Nurse, developing extensive expertise in the management and holistic care of patients living with ILD. As a Nurse Prescriber and member of a specialist ILD nursing team, she is committed to delivering high-quality, patient-centred care and supporting patients to achieve the best possible quality of life. Alongside her clinical practice, Naomi is passionate about education and professional development. She and her colleagues work to enhance the knowledge and confidence of healthcare professionals involved in ILD care, with the aim of ensuring that patients receive timely, evidence-based and holistic care throughout their journey. Naomi’s career has been driven by a strong commitment to improving the lives of people living with ILD and advancing the standard of care for this patient population.

Michelle Westlake serves as the lead Interstitial Lung Disease Nurse Specialist at North Bristol NHS Trust.She completed her Bachelor of Science in Nursing in the Philippines. She was a ward sister in the Respiratory ward before joining the Bristol Interstitial Lung Disease Service. She is passionate about ILD and committed to supporting patients and colleagues by working collaboratively. She provides education to respiratory colleagues across primary and secondary care.She is a Non-Medical Independent Prescriber providing initiation, monitoring and supply of antifibrotics. She runs a well led nurse clinic and her daily role is generally clinically focussed, seeing new and follow up patients. She is passionate in managing ILD patients and finding ways to manage their End Of Life (EOL) care better. She help introduce the Integrated Palliative Care, Palliative ILD Psychology MDT, Dedicated ReSPECT clinics, Working with St Peters Hospice and Palliative Care teams. She help published the Specialist Palliative Care, Psychology, Interstitial Lung Disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs and did a poster presentation in the American Thoracic Society Conference in San Diego in 2018. She also enjoys running the Bristol Pulmonary Fibrosis Support Group.



Giles Dixon is a Specialist Trainee in Respiratory Medicine and has just completed his PhD in the South West. His research investigates how quantitative CT scanning, a technique where algorithms analyse CT scans to produce biomarkers of disease, can help improve prognostication and disease monitoring in fibrotic interstitial lung disease

Voon Ong is Professor of Experimental Rheumatology and Honorary Consultant Rheumatologist at UCL. His interest focuses on scleroderma spectrum diseases and Raynaud's syndrome. One of his main research interests is in the translational aspects of scleroderma, specifically cytokines and the innate and adaptive immune networks which complements the clinical service at the largest national centre for scleroderma and related diseases. He has led several key studies in the assessment of cytokines as putative biomarkers and therapeutic targets in scleroderma and immune-phenotyping. As the clinical lead in scleroderma at Royal Free UCL, he is the principal investigator in numerous clinical trials in scleroderma and has contributed to major papers published in this field including national guidelines for management of scleroderma and related complications.

Michelle Westlake serves as the lead Interstitial Lung Disease Nurse Specialist at North Bristol NHS Trust.She completed her Bachelor of Science in Nursing in the Philippines. She was a ward sister in the Respiratory ward before joining the Bristol Interstitial Lung Disease Service. She is passionate about ILD and committed to supporting patients and colleagues by working collaboratively. She provides education to respiratory colleagues across primary and secondary care.She is a Non-Medical Independent Prescriber providing initiation, monitoring and supply of antifibrotics. She runs a well led nurse clinic and her daily role is generally clinically focussed, seeing new and follow up patients. She is passionate in managing ILD patients and finding ways to manage their End Of Life (EOL) care better. She help introduce the Integrated Palliative Care, Palliative ILD Psychology MDT, Dedicated ReSPECT clinics, Working with St Peters Hospice and Palliative Care teams. She help published the Specialist Palliative Care, Psychology, Interstitial Lung Disease (ILD) multidisciplinary team meeting: a novel model to address palliative care needs and did a poster presentation in the American Thoracic Society Conference in San Diego in 2018. She also enjoys running the Bristol Pulmonary Fibrosis Support Group.
**Early-Bird Deadline – up to and including 2nd September 2026**
With only a couple of sponsorship spaces remaining, now is the time to secure your place at our upcoming conference. Connect with industry leaders, showcase your organisation, and support an impactful event!
The ILD Interdisciplinary Network (ILD-IN) aims to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.
Annual ILD-IN Conference 2025
The 2024 conference was held on 6–7th October and has now passed.
Thank you to all our attendees, speakers and sponsors. Full details of the next annual conference will be available here soon!
Save The Date For 2025
The ILD Interdisciplinary Network (ILD-IN) aims to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.
